Giuseppe Ciaramella - Sep 17, 2021 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
President & CSO
Signature
/s/ Christine Bellon, Attorney-in-fact
Stock symbol
BEAM
Transactions as of
Sep 17, 2021
Transactions value $
$12,068
Form type
4
Date filed
9/21/2021, 06:00 PM
Previous filing
Jun 30, 2021
Next filing
Dec 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BEAM Common Stock Options Exercise $12.1K +18K +40.24% $0.67* 62.8K Sep 17, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -18K -6.79% $0.00 247K Sep 17, 2021 Common Stock 18K $0.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the stock option shall vest on the first anniversary of the vesting commencement date, February 26, 2018, and the remaining shares shall vest in 36 substantially equal monthly installments thereafter, subject to continued service with the Company through such dates.